Molecular & Cellular Oncology (Sep 2020)

Translation control can shape TP53-dependent cell fate

  • Dario Rizzotto,
  • Sara Zaccara,
  • Annalisa Rossi,
  • Erik Dassi,
  • Alberto Inga

DOI
https://doi.org/10.1080/23723556.2020.1767483
Journal volume & issue
Vol. 7, no. 5

Abstract

Read online

The search for mechanisms underlying different cellular responses to the treatment with Nutlin-3, an MDM2 inhibitor that unleashes p53, revealed a translational control mechanism involving the RNA binding proteins PCBP2 and, particularly, DHX30. Sifting through a multi-functional p53-dependent transcriptional output, this translational control can modulate the activation of cell death pathways.

Keywords